JPS6426517A - Remedy for dysuria - Google Patents
Remedy for dysuriaInfo
- Publication number
- JPS6426517A JPS6426517A JP62181579A JP18157987A JPS6426517A JP S6426517 A JPS6426517 A JP S6426517A JP 62181579 A JP62181579 A JP 62181579A JP 18157987 A JP18157987 A JP 18157987A JP S6426517 A JPS6426517 A JP S6426517A
- Authority
- JP
- Japan
- Prior art keywords
- dysuria
- patient
- urine
- remedy
- action
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
PURPOSE:To obtain a low-toxic remedy for dysuria, exhibiting alpha1-adrenoreceptor blocking action in urinary tract and continuing the action over a long period, by using a compound known to exhibit slow hypotensive action as an active component. CONSTITUTION:The objective remedy for dysuria contains the compound of formula or its pharmacologically allowable acid addition salt (especially preferably hydrochloride) as an active component. The remedying object is a patient complaining dysuria, incontinence of urine, pollakiuria, etc., as subjective symptoms. It is effective to a patient of neurogenic vesical dysuria and a patient of prostate gland obstruction accompanying or without accompanying prostatomegaly to increase the flow rate of urine and decrease the residual urine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62181579A JPS6426517A (en) | 1987-07-21 | 1987-07-21 | Remedy for dysuria |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62181579A JPS6426517A (en) | 1987-07-21 | 1987-07-21 | Remedy for dysuria |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6426517A true JPS6426517A (en) | 1989-01-27 |
Family
ID=16103273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62181579A Pending JPS6426517A (en) | 1987-07-21 | 1987-07-21 | Remedy for dysuria |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6426517A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0416841A2 (en) * | 1989-09-06 | 1991-03-13 | Hitachi Chemical Co., Ltd. | Novel use of 6-[[3-[4-(2- methoxyphenyl)-1-piperazinyl] propyl]amino]-1,3-dimethyluracil for preparing a pharmaceutical for treating urinary obstruction |
US5075308A (en) * | 1989-08-31 | 1991-12-24 | Hitachi Chemical Co., Ltd. | Method for treating urinary obstruction |
WO1992018129A1 (en) * | 1991-04-18 | 1992-10-29 | Bernard Aranda | Use of piribedil derivatives and analogues for the treatment of hyperactive or unstable bladders |
US6602888B2 (en) | 1992-11-13 | 2003-08-05 | Synaptic Pharmaceutical Corporation | Use of α1C specific compounds to treat benign prostatic hyperplasia |
WO2005007155A1 (en) * | 2003-07-16 | 2005-01-27 | Kyowa Hakko Kogyo Co., Ltd. | Medicinal composition |
WO2005089742A1 (en) * | 2004-03-24 | 2005-09-29 | Kissei Pharmaceutical Co., Ltd. | Medicine for prevention or treatment of frequent urination or urinary incontinence |
-
1987
- 1987-07-21 JP JP62181579A patent/JPS6426517A/en active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5075308A (en) * | 1989-08-31 | 1991-12-24 | Hitachi Chemical Co., Ltd. | Method for treating urinary obstruction |
EP0416841A2 (en) * | 1989-09-06 | 1991-03-13 | Hitachi Chemical Co., Ltd. | Novel use of 6-[[3-[4-(2- methoxyphenyl)-1-piperazinyl] propyl]amino]-1,3-dimethyluracil for preparing a pharmaceutical for treating urinary obstruction |
US5145851A (en) * | 1989-09-06 | 1992-09-08 | Hitachi Chemical Co., Ltd. | Method for treating urinary obstruction |
WO1992018129A1 (en) * | 1991-04-18 | 1992-10-29 | Bernard Aranda | Use of piribedil derivatives and analogues for the treatment of hyperactive or unstable bladders |
US5362731A (en) * | 1991-04-18 | 1994-11-08 | Bernard Aranda | Use of piribedil derivatives and analogs for the treatment of hyperactive or unstable bladders |
US6602888B2 (en) | 1992-11-13 | 2003-08-05 | Synaptic Pharmaceutical Corporation | Use of α1C specific compounds to treat benign prostatic hyperplasia |
WO2005007155A1 (en) * | 2003-07-16 | 2005-01-27 | Kyowa Hakko Kogyo Co., Ltd. | Medicinal composition |
WO2005089742A1 (en) * | 2004-03-24 | 2005-09-29 | Kissei Pharmaceutical Co., Ltd. | Medicine for prevention or treatment of frequent urination or urinary incontinence |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Harris et al. | Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production | |
ATE395056T1 (en) | USE OF R-(+)-2-(3-DIISOPROPYLAMINO-1-PHENYLPROPYL)-4-HYDROXY-METHYL-PHENYLISOBUTYRIC ACID ESTER HYDROGEN FUMARATE FOR THE TREATMENT OF URINARY INCONTINENCE AND OTHER SPASMOGENIC CONDITIONS | |
FI935675A0 (en) | Pyrazolopyrimidiner | |
DE69931794D1 (en) | THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF SLUDGE HYPERSECRETION | |
WO2001039759A3 (en) | Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds | |
DE69108048D1 (en) | DERIVATIVES OF HYDROXAMIC ACID AND N-HYDROXY URINE, AND THEIR USE. | |
BR0313371A (en) | Compound, use of a compound and disease treatment method | |
DE60021873D1 (en) | PREPARATION FOR THE PROPHYLAXIS OR TREATMENT OF DEMENTIA DISEASE CONTAINS A HYDROXYZIMOTE ACID DERIVATIVE OR AN EXTRACT OF A PLANT OF THE GENUS ANGELICA CONTAINING THIS ACID. | |
DE69006684D1 (en) | Use of a composition for the manufacture of a medicament for the treatment of the symptoms of abstinence. | |
DE69833059D1 (en) | Use of botulinum toxin for the treatment of urinary incontinence | |
MA25809A1 (en) | ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS | |
BR9917038A (en) | Compound, pharmaceutical composition, method of modulating chemokine receptor activity, method of treatment or prevention of inflammatory diseases, method of treatment or prevention of asthma and method of treatment or prevention of inflammatory disorders | |
EA199900669A1 (en) | INTERMEDIATE COMPOUNDS FOR OBTAINING N-[AMINOIMINOMETHYL OR AMINOMETHYL-PHENYL] SUBSTITUTED PROPYLAMIDES | |
EA199900542A1 (en) | COMPOUNDS OF SULPHONIC ACID OR SULPHONYLAMINO-N- (HETEROARALKYL) -ASAGHETHROCYCLOSYME | |
BR9910899A (en) | N- (hetero-aralkyl) -azaeterocyclamide sulfonic or sulfonylamino compounds | |
GB2075341B (en) | Pharmaceutical compositions | |
JPS6426517A (en) | Remedy for dysuria | |
DE69210654D1 (en) | Use of tomoxetine to treat dysfunction of the lower urinary tract | |
WO2002096362A3 (en) | Method for treating fibrotic diseases or other indications vi | |
EP1284265A4 (en) | Benzothiophene derivatives and medicinal use thereof | |
DE69727378D1 (en) | USE OF 5-HTIA RECEPTOR ANTAGONISTS FOR TREATING URINE INCONTINENCE | |
WO2001003688A3 (en) | Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds | |
ATE442137T1 (en) | MEDICATION FOR THE PREVENTION OR TREATMENT OF FREQUENT URINATION OR URINARY INCONTINENCE | |
ATE277926T1 (en) | TRIZYCLIC VASOPRESSIN AGONISTS | |
ATE192040T1 (en) | ACTIVE INGREDIENTS AGAINST ARTERIOSCLEROSIS |